Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sativex for inpatient cannabis withdrawal
ACTRN12611000398909Phase 2Not yet recruiting
- Sponsor
- University of New South Wales
- Start
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in cannabis withdrawal comparing Sativex with Placebo spray (2 arms). Primary endpoints: Cannabis withdrawal severity, Treatment completion and 1 more. Planned start Jul 2011; status: not yet recruiting.
02
Drugs
cannabidiol
03
Conditions
cannabis withdrawal
Beyond the preview
Go deeper on ACTRN12611000398909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611000398909.